Oncology

News

Ex-Taris CEO Tony Kingsley claims tenure as Scholar Rock's n...

After more than eight years at the helm of US biotech Scholar Rock, Nagesh Mahanthappa is standing down as CEO, to be replaced by biopharma industry veteran Tony Kingsley.<

Views & Analysis

Making it as an oncology biotech in the united kingdom

Making it as an oncology biotech in the UK

We speak to R&D experts to find out how oncology biotechs can get the support they need to be successful in the competitive UK ecosystem

Views & Analysis

Helping HCPs navigate the ever-evolving advanced cancer land...

OPEN Health’s Christine Drewienkiewicz, Sara Black and Annie Rankin on advances in modern oncology and how pharma can help ensure maximum patient benefit

Views & Analysis

Adapting for the future of oncology

External pressures and rapid scientific advancements are changing oncology forever, and innovative trials are needed to keep pace.

News

AI startup Nucleai has immuno-oncology treatment failures in...

Israeli company Nucleai is putting artificial intelligence to work to discover why so many cancer patients don’t respond to immunotherapies, with the help of Swiss drugmaker De

News

AI health record scanning could identify pancreatic cancer e...

Artificial intelligence (AI) could hold the key to identifying people at risk of pancreatic cancer early, allowing them to start potentially life-saving treatment more quickly.

Ex-Taris CEO Tony Kingsley claims tenure as Scholar Rock's n...

Making it as an oncology biotech in the UK

Helping HCPs navigate the ever-evolving advanced cancer land...

Adapting for the future of oncology

AI startup Nucleai has immuno-oncology treatment failures in...

AI health record scanning could identify pancreatic cancer e...

Roche culls myostatin candidate from obesity pipeline

Discover a new era of healthcare panel engagement: Grounded ...

Oncology

Editor's Picks